In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 327 for your search:
Drug:  topotecan hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E7593, E7593

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SB-104864/039, NCI-V94-0490

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SB-104864/090, NCI-V95-0673

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SEQUUS-30-49, NCI-V97-1257

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-SKF-1598, SB-104864-A/396, NCI-G99-1524, NCT00003917

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067138, GOG-0179, ECOG-G0179, NCT00003945

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: D9803, NCI-2012-02302, IRS-D9803, COG-D9803, POG-D9803, CDR0000067157, CCG-D9803, U10CA098543, NCT00003958

9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: A3973, COG-A3973, CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, CDR0000067429, NCT00004188

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067994, AGOSG-OVAR-7, NCI-V00-1602, NCT00006454

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: GOG-0182, NCI-2012-02376, SWOG-G0182, CDR0000068467, ISRCTN41636183, MRC-ICON5, ECOG-G0182, U10CA027469, NCT00011986

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-070144, SB-389, SB-SKF-104864A, SB-SKF-1501, NCI-G02-2092, NCT00041015

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 365 days to 20 years
Sponsor: NCI
Protocol IDs: POG-9340-42, POG-9340, POG-9341, POG-9342

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000306463, GOG-0204, NCT00064077

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03087, TLK-286.3017, NCT00078884

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: RET5, P01CA023099, NCT00186888

17.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Under 21
Sponsor: Other
Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 3104000, NCT00437307

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0531, COG-ANBL0531, CDR0000554708, NCT00499616

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN32313R, NCT00477282

21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 to 29
Sponsor: NCI
Protocol IDs: NCI-2009-00369, AEWS0521, U10CA098543, COG-AEWS0521, NCT00516295

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMR PH GL 2007 CL001, NCT00547651

23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0532, COG-ANBL0532, CDR0000576571, NCT00567567

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01084, CDR0000628746, GOG-0240, U10CA180868, U10CA027469, NCT00803062

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: OV16, CAN-NCIC-OV16, EORTC-55012, GEICO-0101, CDR0000069129, NCT00028743
1     
New Search